Hepatitis B surface antibody (anti-HBs):This test indicates immunity from HBV infection, either due to recovery after an infection or from vaccination. Total antibody to hepatitis B core antigen (anti-HBc):This test measures antibodies that show if you have ever had an active HBV infection. An...
Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection. Liver Transpl - Franchello, Ghisetti, et al.Franchello Alessandro,Ghisetti Valeria,Marzano Alfredo,Romagnoli Renato,Salizzoni Mauro.Transplantation of ...
CTCs were detected using a mesenchymal CTC kit, and the clinical and pathological characteristics of CTCs were compared with those of cell surface vimentin-positive CTCs (CSV-CTCs). Disease-free survival (DFS) was assessed and used as an indicator of CTC phenotype-related prognosis. Univariate ...
To evaluate prenatal maternal hepatitis B virus (HBV) screening and post-vaccination hepatitis B surface antigen (HBsAg) and antibody to hepatitis B surface antigen (anti-HBs) status and titers of babies born to HBsAg positive mothers, and to provide evidence for development of standard postvaccina...
On the other hand, phosphorylated p62 was barely detectable in tumour and non-tumour regions of HCC patients positive for anti-hepatitis B virus (HBV) antibody (Fig. 8a); the difference between HBV- and HCV-positive patients was statistically significant (Po0.001). Keap1 levels were also ...
Suppression of CD133 enhances chemoradiosensitivity of HepG2-CD133+ cells. (A and B) Compared to the shNC and the blank control group, both the GIR of cisplatin and doxorubicin were higher in the shCD133 group. (C) After radiation treatment with doses from 0 to 10 Gy, the survival fr...
(B) HEK293T cells were co-transfected with pSox4 3`UTR-Luc and indicated miRNA mimics. Luciferase activity was measured and normalized to the control. The results are presented as means ±SD (n = 3). (C) HepG2.2.15 cells were transfected with the miRNA mimics. (D) HepG2 cells...
(glutamate-cysteine ligase catalytic subunit) and Nqo1 in Huh7 cells expressing S351E (Fig. 1b). We verified the effect of S351E in other cancer cell lines, including Hepa1, JHH1 and HepG2, in which the endogenous levels of phosphorylated p62 were very low (Figs 1band2). In ...
These trials have reduction of acute and late toxicities associated with current aggressive treatment options in mind and can roughly be divided into two categories: de-intensification of chemotherapy by replacement by cetuximab, a chimeric monoclonal antibody against EGFR, and de-intensification of the...